Point-of-care (POC) diagnostics are used across care settings, from consumers’ homes to bedsides in hospital intensive care units. The point-of-care diagnostic industry marks the shift from curative to predictive medicine, and globally millions of dollars are spent annually on the market. Point-of-care diagnostics represent the middle ground between rapid testing performed near a patient that is low in complexity, and the advanced technology that uses clinical molecular diagnostics. To this end, point-of-care diagnostics seek rapid results with an ease-of-use operation. This collection of reports provides insight into the point-of-care diagnostics market’s developments, like its targeting of infectious diseases as initial objectives. Kalorama Information has routinely profiled the clinical POC diagnostics market in its product development trends, market opportunities, and current and future sales in several product categories. Our reports are leading resources for industry professionals interested in molecular POC diagnostics, retail clinic diagnostics, and physician office laboratory (POL) markets worldwide.
- Display 45 Products per page
Published: April 16, 2014 | Price: $600.00 – $1,200.00
Results of the 2014 (Jan-Feb 2014) survey of glucose meter users.Published: April 7, 2020 | Price: $4,000.00 – $8,000.00
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...Published: August 15, 2012 | Price: $995.00 – $1,995.00
Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever. Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require...Published: October 16, 2017 | Price: $3,600.00 – $7,200.00
Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose Market, Electrolytes Market, Cardiac Biomarkers Market, Enzymes Market, Proteins Market, Drugs of Abuse Market, Therapeutic Drugs Market, HbA1c Market, Other Commonly Tested Analytes] by Region) This Kalorama Information report, Clinical Chemistry Markets, examines the global market for clinical chemistry products and procedures. Among the products covered are instruments, reagents, and supporting consumables used worldwide in core laboratory and point-of-care (POC) medical testing. Clinical chemistry instruments consist of large multifunctional workstations...Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: November 1, 2008 | Price: $1,990.00 – $2,000.00
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012. With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: July 19, 2017 | Price: $3,360.00 – $6,720.00
Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total) Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies,...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: September 9, 2018 | Price: $5,000.00 – $10,000.00
Kalorama Information 2018 Regional IVD Market Bundle (IVD in China, The IVD Market in South Korea, The IVD Market in Vietnam) This Kalorama Information (KI) Market Research Bundle is a combination of 3 complete KI in vitro diagnostics (IVD) reports, including IVD in China, The IVD Market in South Korea and The IVD Market in Vietnam. The reports provide an overview of the IVD markets in China, South Korea and Vietnam. The revenue data provided give an overview of developments...Published: September 18, 2018 | Price: $3,500.00 – $7,990.00
IVD in Eastern Europe IVD companies continue to explore opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class. Eastern European markets are ripe for change. Many countries are engaging in healthcare reform programs to meet the growing demand for innovative products while containing costs in an increasingly...Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: October 4, 2016 | Price: $2,396.00 – $4,792.00
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...Published: January 14, 2015 | Price: $1,995.00 – $3,995.00
This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD tests. The report provides global 2014 sales of equipment, reagents and other products related to in vitro diagnostic tests. Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include: Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other) Molecular (Infectious Disease [inc. molecular tests for...Published: October 11, 2019 | Price: $5,000.00 – $10,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...Published: August 15, 2017 | Price: $200.00 – $400.00
Coverage of major IVD industry events and trends July 2017.Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: July 25, 2017 | Price: $2,800.00 – $5,600.00
Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the major market sub-segments for 2016-2021: In Vitro Diagnostic Sales by Market Segment (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose,...Published: August 15, 2014 | Price: $3,995.00 – $7,990.00
Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...Published: January 26, 2016 | Price: $796.00 – $1,592.00
Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...Published: December 29, 2015 | Price: $696.50 – $1,393.00
Point of Care (POC) Pregnancy and Fertility Testing Market The female reproductive system is complex both in structure and in function. From birth to senescence, the organs of the female reproductive system function in concert with each other, with the brain, and with other endocrine organs. This integrated functioning constitutes some of the most intricate and elegant processes of the human body. Because the functioning of the female reproductive system has an enormous impact on the life of the individual...Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: March 22, 2018 | Price: $2,995.00 – $5,995.00
This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players. As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...Published: November 1, 2009 | Price: $3,995.00 – $7,990.00
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot...Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: September 14, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in VietnamThe IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious...Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...